Prions are self-replicating protein aggregates and are the primary causative factor in a number of neurological diseases in mammals. The prion protein (PrP) undergoes a conformational transformation leading to aggregation into an infectious cellular pathogen. Prion-like protein spreading and transmission of aggregates between cells have also been demonstrated for other proteins associated with Alzheimer disease and Parkinson disease. This protein-only phenomenon may therefore have broader implications in neurodegenerative disorders. The minireviews in this thematic series highlight the recent advances in prion biology and the roles these unique proteins play in disease.
It has been more than 30 years since Stanley Prusiner coined the term "prion" to describe a novel class of infectious agent that causes rare degenerative diseases of the brain in humans and animals (1) . It was speculated that unlike viruses or bacteria, prions were composed solely of protein and were capable of replicating in the absence of any nucleic acids. With further work, it became apparent that prions were composed of a hostencoded protein, the prion protein (PrP), 2 which could exist in multiple conformational states: PrP C , the properly folded cellular isoform, and PrP Sc , the misfolded and infectious isoform associated with prion disease (2) . Replication of prions occurs via a conformational remodeling event in which PrP Sc induces the misfolding of PrP C in a template-directed fashion.
Although the notion of self-replicating proteins in prion disease had been previously entertained (3), The "protein-only hypothesis" was initially the subject of considerable debate. The existence of multiple stable conformations of a single protein in the absence of any post-translational modifications was seen as a direct violation of Anfinsen's dogma that the native structure of a globular protein is governed entirely by its primary amino acid sequence (4) . Furthermore, many refused to believe that a biological agent could replicate in the absence of nucleic acids (5) . In particular, the existence of distinct "strains" of prions seemed implausible without invoking a mutation in a nucleic acid genome (6) . Today, the protein-only hypothesis is widely accepted and has been proven beyond a reasonable doubt, the final proof coming from the demonstration that bacterially produced PrP can be refolded into an infectious conformation (7) .
In addition to constituting a unique biological paradigm, there is also a sensationalist component to the story of prions. Whether it be the transmission of kuru among the Fore tribe of Papua New Guinea by ritualistic cannibalism (8) or the epidemic of variant Creutzfeldt-Jakob disease in Europe that occurred via consumption of food products contaminated with "mad cow disease" (9), prions often generate considerable public attention.
Prions were originally defined as "small proteinaceous infectious particles that are resistant to most procedures that modify nucleic acids" (1). However, as it became recognized that the molecular mechanism of prion replication involved templatedirected conformational change, the definition of a prion was expanded to encompass other biological phenomena. Although human prion diseases are very rare, it has recently been suggested that the pathogenic mechanisms in much more common neurodegenerative illnesses, such as Alzheimer disease and Parkinson disease, may also involve proteins that become prions (10) .
Because these diseases are unlikely to be transmissible from person to person, there is considerable debate over whether the term "prion" should be applied (11) . Nomenclature notwithstanding, there is very little scientific disagreement that the aggregation-prone proteins at the center of these diseases can attain properties that are reminiscent of prions (12) . Hence, prions and other self-propagating proteins seem destined to remain at the forefront of scientific curiosity for the foreseeable future.
This thematic series consists of four minireviews (13) (14) (15) (16) ) that cover the current knowledge of prion replication, transmission, and cellular toxicity. These reviews also highlight the importance of these pathways to disease pathogenesis and discuss the potential for therapeutic strategies to control prionlike replication in neurodegenerative diseases.
In the first minireview (13), Joel Watts and Stanley Prusiner discuss the key contributions that mouse models have made to the understanding of prion infectivity and the evaluation of promising therapies to treat these diseases. The importance of transgenics to examine the spontaneous generation of prions is highlighted, and the potential for the next generation of in vivo models is also discussed.
The second minireview in this series (14) , by Surachai Supattapone, describes the recent advances in synthetic prions and the role of cofactors in the generation of infectious species. The ability of cofactor molecules to enhance infectivity and their impact on prion strain variations by mediating conformational transformations as well as the prospects for future research in this area are highlighted.
The next minireview (15) , written by Brandon Holmes and Marc Diamond, summarizes the prion-like transmission of the Tau protein associated with Alzheimer disease and a variety of tauopathies. Intracellular Tau aggregates can be released and taken up by neighboring cells, leading to propagation of these toxic species through the brain. The mechanisms of cellular uptake are discussed, and the possibilities for therapeutic interventions to remove the prion-like aggregates are summarized in this review.
The final minireview (16) , written by Giovanna Mallucci and colleagues, Mark Halliday and Helois Radford, examines the relationship between the generation and spreading of prions and the observed neurotoxicity of these misfolded pathogenic agents. Recent studies have demonstrated the potential for distinct pathways of prion formation as compared with toxicity. Involvement of the unfolded protein response in attenuating toxicity, in the absence of any changes in prion replication, point to new approaches in how these diseases may be treated.
This comprehensive collection of minireviews provides an overview of the current knowledge of prion transmission and replication and the underlying mechanisms of neurotoxicity. It is hoped that this thematic series will serve as a useful introduction to those currently entering this exciting field of research and also provide a useful overview for researchers examining prion biology.
